JNJ Maintains by Wells Fargo -- Price Target Lowered to $275

gurufocus.com · 2026-10-14

Johnson & Johnson Analyst Rating Update On October 10, 2026, Wells Fargo maintained an Overweight rating for Johnson & Johnson (JNJ) while adjusting its pric

TickrTrends take: Wells Fargo's reduction of its price target for JNJ to $275 aligns with TickrTrends' current assessment that the stock is overvalued within the Healthcare sector. This analyst action provides a concrete benchmark against which investors can compare the stock's current trading level and monitor whether the market adjusts its valuation accordingly. Valuation-conscious observers should track whether additional analyst price target reductions or earnings developments follow this Wells Fargo move, as such shifts could either validate or challenge TickrTrends' overvaluation classification.

Read the full story at gurufocus.com →